AAM
Azzad Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $540K | Buy |
17,147
+300
| +2% | +$9.46K | 0.06% | 267 |
|
|
2025
Q1 | $552K | Buy |
+16,847
| New | +$552K | 0.07% | 260 |
|
|
2024
Q4 | – | Sell |
-15,641
| Closed | -$488K | – | 294 |
|
|
2024
Q3 | $488K | Sell |
15,641
-96
| -0.6% | -$2.99K | 0.05% | 275 |
|
|
2024
Q2 | $421K | Buy |
15,737
+40
| +0.3% | +$1.07K | 0.05% | 270 |
|
|
2024
Q1 | $535K | Buy |
15,697
+29
| +0.2% | +$989 | 0.06% | 265 |
|
|
2023
Q4 | $453K | Buy |
15,668
+199
| +1% | +$5.76K | 0.06% | 277 |
|
|
2023
Q3 | $426K | Buy |
15,469
+350
| +2% | +$9.65K | 0.06% | 272 |
|
|
2023
Q2 | $454K | Buy |
15,119
+304
| +2% | +$9.14K | 0.06% | 282 |
|
|
2023
Q1 | $537K | Buy |
14,815
+254
| +2% | +$9.2K | 0.08% | 266 |
|
|
2022
Q4 | $519K | Buy |
14,561
+72
| +0.5% | +$2.57K | 0.08% | 263 |
|
|
2022
Q3 | $490K | Sell |
14,489
-101
| -0.7% | -$3.42K | 0.05% | 342 |
|
|
2022
Q2 | $422K | Buy |
14,590
+1,823
| +14% | +$52.7K | 0.04% | 345 |
|
|
2022
Q1 | $413K | Sell |
12,767
-7,436
| -37% | -$240K | 0.06% | 282 |
|
|
2021
Q4 | $589K | Sell |
20,203
-265
| -1% | -$7.73K | 0.08% | 281 |
|
|
2021
Q3 | $546K | Buy |
20,468
+4,308
| +27% | +$115K | 0.08% | 283 |
|
|
2021
Q2 | $498K | Sell |
16,160
-204
| -1% | -$6.28K | 0.07% | 284 |
|
|
2021
Q1 | $428K | Buy |
+16,364
| New | +$428K | 0.07% | 282 |
|